West Cancer Center has awarded four intramural grants for cancer research. The awarded grants, each valued at $50,000, were among 20 proposals received by West Cancer Center for its annual grant awarding process.
“At West Cancer Center, it is of paramount importance that we provide the necessary funding to support impactful cancer research, right here in Memphis,” said Ari VanderWalde, MD, Director of Clinical Research at West Cancer Center and Associate Vice Chancellor of Research, Clinical Trials, at the University of Tennessee Health Science Center (UTHSC). “This year’s awarded projects demonstrate a commitment to translating basic, scientific research into innovative patient care in the clinical setting. These projects – and researchers – are but a few examples of the drive for innovation that exists in our medical community, particularly in the field of oncology.”
This year’s recipients and projects include:
• Matthew Ballo, MD, FACR and Enrique Izaguirre, PhD, DABR, Department of Radiation Oncology, UTHSC – Awarded $50,000 for their project titled “Novel 3D Printed Applicators for Advance Skin Cancer Brachytherapy.”
• Gustavo A. Miranda-Carboni, PhD, Division of Hematology/Oncology, UTHSC – Awarded $50,000 for his research in the study of “Monoterpene Natural Products Against TNBC.”
• Lawrence M. Pfeffer, PhD, Department of Pathology and Laboratory Medicine, UTHSC – Awarded $50,000 for his research proposal titled “The Role of APELA in Glioblastoma.”
• Junming Yue, PhD, Department of Pathology, UTHSC – Awarded $50,000 for his research testing MTF1 as a new drug target in treating ovarian cancer.